Govoni, Stefano, 1950-
Stefano Govoni
Govoni, Stefano
Govoni, S.
VIAF ID: 256189898 (Personal)
Permalink: http://viaf.org/viaf/256189898
Preferred Forms
- 200 _ | ‡a Govoni ‡b Stefano ‡f 1950-....
-
- 100 1 _ ‡a Govoni, S.
-
-
- 100 1 _ ‡a Govoni, Stefano
- 100 1 _ ‡a Govoni, Stefano
-
- 100 1 _ ‡a Govoni, Stefano ‡d 1950-
-
-
-
- 100 1 _ ‡a Govoni, Stefano, ‡d 1950-
-
- 100 0 _ ‡a Stefano Govoni
4xx's: Alternate Name Forms (7)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Brain and Heart Dynamics | |
Calcium antagonists : pharmacology and clinical research | |
The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. | |
Dementias : biological bases and clinical approach to treatment | |
Do we need pharmacogenetics to personalize antidepressant therapy? | |
Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. | |
Effect of calcium entry blockade on ethanol-induced changes in bronchomotor tone | |
Effect of desmethyldiazepam and chlordesmethyldiazepam on 3?,5?-cyclic guanosine monophosphate levels in rat cerebellum | |
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. | |
Effect of in vivo and in vitro ethanol on adrenergic and purinergic responses of the bisected rat vas deferens to low and high frequency pulses. | |
Effects of chronic low-dose ethanol intake on sexual behavior in rats | |
Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study. | |
ELAV-GAP43 pathway activation following combined exposure to cocaine and stress. | |
Emerging targets for the pharmacology of learning and memory. | |
Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts. | |
Estrogen receptor alpha and APOEepsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. | |
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. | |
Expression and activation of SH2/PTB-containing ShcA adaptor protein reflects the pattern of neurogenesis in the mammalian brain | |
Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts | |
Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms | |
Fibroblasts from Alzheimer's disease donors do not differ from controls in response to heat shock | |
Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein | |
Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. | |
Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain | |
Handbook of the autonomic nervous system in health and disease | |
High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly. | |
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival | |
How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments | |
Identification of peptides with ELAV-like mRNA-stabilizing effect: an integrated in vitro/in silico approach | |
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 | |
In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee | |
Increase of the RNA-binding protein HuD and posttranscriptional up-regulation of the GAP-43 gene during spatial memory | |
Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. | |
Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients | |
Influence of different anaesthetics on extracellular aminoacids in rat brain. | |
Inhibitory effects of beta-amyloid on the nicotinic receptors which stimulate glutamate release in rat hippocampus: the glial contribution | |
Inositol 1,4,5-trisphosphate receptor and ryanodine receptor in the aging brain of Wistar rats. | |
Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses. | |
Ischemia-induced glutamate release in rat frontoparietal cortex after chronic alcohol and withdrawal | |
Lead contamination in the mallard (Anas platyrhynchos) in Italy. | |
Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. | |
Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis. | |
Modification of cell to cell signals during normal and pathological aging | |
Modulation of Rack-1/PKCβII signalling by soluble AβPPα in SH-SY5Y cells | |
Modulation of rat skeletal muscle chloride channels by activators and inhibitors of protein kinase C. | |
Neuronal control of brain microvessel function | |
Neurotensin effect on dopamine release and calcium transport in rat striatum: interactions with diphenylalkylamine calcium antagonists. | |
NGF and heart: Is there a role in heart disease? | |
Non-virally mediated gene transfer into human central nervous system precursor cells. | |
Novel approaches to the post-myocardial infarction/heart failure neural remodeling. | |
Novel potent sigma 1 ligands: N-[omega-(tetralin-1-yl)alkyl]piperidine derivatives. | |
Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients | |
p53 at the crossroads between cancer and neurodegeneration | |
Patologia cerebral | |
Pentraxins and Alzheimer's disease: at the interface between biomarkers and pharmacological targets. | |
The Peptidyl-prolyl Isomerase Pin1 in Neuronal Signaling: from Neurodevelopment to Neurodegeneration | |
Peripheral cells as an investigational tool for Alzheimer's disease. | |
Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53. | |
The pharmacology of amyloid precursor protein processing. | |
Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role--relevance for Alzheimer pathology | |
PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment | |
PKC translocation in rat brain cortex is promoted in vivo and in vitro by alpha-glycerylphosphorylcholine, a cognition-enhancing drug | |
The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. | |
PKCbetaII/HuR/VEGF: A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression | |
Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS. | |
Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough | |
Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. | |
Recent advances in the pharmacology of Ca2+ and K+ channels | |
Recruitment of casein kinase 2 is involved in AbetaPP processing following cholinergic stimulation | |
Regulation of protein kinase C in NG108-15 cell differentiation | |
The role of anchoring protein RACK1 in PKC activation in the ageing rat brain | |
Selective impairment of noradrenergic transmission in the bisected rat vas deferens following photochemically-induced cerebral ischaemia. | |
Senescence of the brain: focus on cognitive kinases. | |
Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. | |
Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state? | |
Specific neuromodulatory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen | |
Specific role for protein kinase C alpha in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts | |
STAT signalling in the mature and aging brain. | |
Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. | |
Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. | |
Wild type but not mutant APP is involved in protective adaptive responses against oxidants | |
Zyxin is a novel target for β-amyloid peptide: characterization of its role in Alzheimer's pathogenesis |